Medicaid Coverage and Prior Authorization for Antiobesity Glucagon-Like Peptide-1 Receptor Agonists: A Cross-Sectional Study of State Policies
Journal of General Internal Medicine
Authors
Matthew J Klebanoff, Ashwin K Chetty, Jalpa A Doshi
CHIBE Experts
Research Areas
You might also be interested in...
View all publications-
Transplantation in Mandatory Kidney Payment Models: Understanding the Potential Influence of the ESRD Treatment Choices Model on the Increasing Organ Transplant Access Model
Kidney MedicineJanuary 1, 2026 -
Specialty Oral Anticancer Prescription Fill Rates After Medicare Part D Cost-Sharing Changes in 2024
JAMA NetworkDecember 29, 2025 -
Payments to Physician Practices and Incentives to Serve Different Racial and Ethnic Groups
JAMA Health ForumNovember 26, 2025 -
Changes in Health Care Utilization and Low-Value Service Use After Risk-Based Contract Adoption in Medicare Advantage
JAMA Internal MedicineNovember 10, 2025 -
Unfairness toward rural beneficiaries in Medicare's hierarchical conditions categories score
Health Affairs ScholarSeptember 23, 2025 -
Physician and Hospital Performance in Medicare’s Updated Bundled-Payment Model for Joint Replacement
JAMA Health ForumJuly 25, 2025 -
A Physician and Practice Incentive Intervention to Increase Referrals to High-Value Settings
NEJM CatalystJuly 16, 2025 -
Savings Associated With Bundled Payments for Outpatient Spine Surgery Among Medicare Beneficiaries
JAMA Health ForumJuly 11, 2025 -
The Corporatization of U.S. Health Care — A New Perspective Series
The New England Journal of MedicineJuly 2, 2025 -
Inflation Reduction Act Provisions and Medicare Part D Out-of-Pocket Costs for Specialty Drugs
JAMA Health ForumMay 16, 2025 -
Association of Stratified Benchmarks With Financial Penalties in the ESRD Treatment Choices Model
JAMAMay 7, 2025 -
Paying More for Primary Care—A New Approach by Medicare
JAMADecember 12, 2024